Colin White, President of Invetech, has a conversation with Professor Jeanne Liedtka on leadership, the subject of her new book The Catalyst.

Invetech’s molecular biologist Rebecca Newman shares her takeaway from the Molecular Med Tri-Conference 2014

Invetech shares some of its winning strategies for developing truly innovative devices.

David James discusses small-batch-size production in a supplement to BioProcess International.

The IVD industry has the opportunity to not only address world poverty, but also achieve strong commercial return.

We talk with Bill Hill, a Director at Invetech, about how to increase the chances of turning a great idea into an iconic product.

David James outlines the pros and cons of product customization and describes methods for success.

Alan Morris and Andreas Knaack of Invetech go into the details of what makes great products just so great.

Improving the reliability of complex instruments is critical in avoiding unexpected losses and increasing overall profitability.

The product definition process can overlook optimal solutions if existing practices or favored technologies are accepted without adequate questioning.

Here we describe the challenges and advantages to different methods of cost reduction that leave the quality of the final product intact.